RYTM - RHYTHM PHARMACEUTICALS, INC.

QQQ $ 445.29 $ 0.49 (0.11 %)

DIA $ 394.84 $ -0.25 (-0.06 %)

SPY $ 522.32 $ 0.10 (0.03 %)

TLT $ 90.80 $ 0.46 (0.51 %)

GLD $ 218.30 $ 2.04 (0.94 %)

Previous Close

$ 40.2

Open

$ 40.47

Bid

$ 40.26 x 320

Ask

$ 0.00 x 0

Day's Range

$ 40.26 - $ 40.99

52 Week Range

$ 15.50 - $ 52.57

Volume

407,665

Average Volume

Market Cap

2.45B

Beta (5Y Monthly)

$ 1.03

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-07-2024	03-31-2024	10-Q
2	02-29-2024	12-31-2023	10-K
3	11-08-2023	09-30-2023	10-Q
4	08-01-2023	06-30-2023	10-Q
5	05-02-2023	03-31-2023	10-Q
6	03-01-2023	12-31-2022	10-K
7	11-08-2022	09-30-2022	10-Q
8	08-03-2022	06-30-2022	10-Q
9	05-03-2022	03-31-2022	10-Q
10	03-01-2022	12-31-2021	10-K
11	11-02-2021	09-30-2021	10-Q
12	08-03-2021	06-30-2021	10-Q
13	05-03-2021	03-31-2021	10-Q
14	03-01-2021	12-31-2020	10-K
15	11-02-2020	09-30-2020	10-Q
16	08-03-2020	06-30-2020	10-Q
17	05-04-2020	03-31-2020	10-Q
18	03-02-2020	12-31-2019	10-K
19	11-01-2019	09-30-2019	10-Q
20	07-29-2019	06-30-2019	10-Q
21	05-03-2019	03-31-2019	10-Q
22	03-08-2019	12-31-2018	10-K
23	11-09-2018	09-30-2018	10-Q
24	08-08-2018	06-30-2018	10-Q
25	05-14-2018	03-31-2018	10-Q
26	03-12-2018	12-31-2017	10-K
27	11-14-2017	09-30-2017	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Canaccord Genuity Maintains Buy on Rhythm ...
05/08/2024 16:55:55

Canaccord Genuity analyst Whitney Ijem maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and lowers the price target...

B of A Securities Downgrades Rhythm Pharma...
05/08/2024 10:17:30

B of A Securities analyst Tazeen Ahmad downgrades Rhythm Pharmaceuticals (NASDAQ:RYTM) from Buy to Neutral and lowers the pr...

Needham Maintains Buy on Rhythm Pharmaceut...
05/07/2024 18:11:57

Needham analyst Joseph Stringer maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and lowers the price target from $...

Rhythm Pharmaceuticals Q1 2024 GAAP EPS $(...
05/07/2024 11:02:02

Rhythm Pharmaceuticals Presents Data From ...
05/06/2024 12:15:08

-- Oral presentation showcased previously disclosed data that demonstrate setmelanotide achieved 3.04 mean reduction in BMI-Z s...

Rhythm Pharmaceuticals Announces Publicati...
04/29/2024 22:49:41

- Publication highlights administration of setmelanotide therapy resulted in a mean percent reduction in BMI of 15% at 16 weeks...

Analyst Expectations For Rhythm Pharmaceut...
04/26/2024 13:01:18

Needham Reiterates Buy on Rhythm Pharmaceu...
04/26/2024 10:39:34

Needham analyst Joseph Stringer reiterates Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and maintains $50 price target.

jim-cramer-is-willing-to-let-this-pharma-stock-catch-fire-advises-not-to-sell-mckesson

Jim Cramer Is 'Willing To Let This Pharma ...
04/19/2024 12:46:13

The "Mad Money" host recommended buying some Marvell Technology, and then wait until under $60 to buy the rest.

Wells Fargo Maintains Overweight on Rhythm...
04/18/2024 12:59:42

Wells Fargo analyst Derek Archila maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Overweight and lowers the price targ...

5 Analysts Assess Rhythm Pharmaceuticals: ...
04/10/2024 16:00:49

Needham Reiterates Buy on Rhythm Pharmaceu...
04/10/2024 10:26:02

Needham analyst Joseph Stringer reiterates Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and maintains $50 price target.

Rhythm Pharmaceuticals Announces First Pat...
03/25/2024 12:04:49

- Three-part study to evaluate safety, tolerability and pharmacokinetics now underway -- -- RM-718 showed potential to reduce b...

Analyst Expectations For Rhythm Pharmaceut...
02/22/2024 18:00:42

Needham Reiterates Buy on Rhythm Pharmaceu...
02/22/2024 17:25:18

Needham analyst Joseph Stringer reiterates Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Buy and maintains $50 price target.

Rhythm Pharmaceuticals Announced Plans To ...
02/22/2024 12:09:24

Rhythm Pharmaceuticals Says Cash On-hand O...
02/22/2024 12:08:44

Rhythm Pharmaceuticals Q4 EPS $(0.70) Miss...
02/22/2024 12:05:50

Rhythm Pharmaceuticals (NASDAQ:RYTM) reported quarterly losses of $(0.70) per share which missed the analyst consensus estimate...

Earnings Scheduled For February 22, 2024
02/22/2024 10:27:06

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

Preview: Rhythm Pharmaceuticals's Earnings
02/21/2024 18:01:13